These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6858413)

  • 21. Discordant HLA haplotype segregation in familial Crohn's disease.
    Eade OE; Moulton C; MacPherson BR; Andre-Ukena SS; Albertini RJ; Beeken WL
    Gastroenterology; 1980 Aug; 79(2):271-5. PubMed ID: 7399230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D.
    Hugot JP; Laurent-Puig P; Gower-Rousseau C; Caillat-Zucman S; Beaugerie L; Dupas JL; Van Gossum A; Bonäit-Pellie C; Cortot A; Thomas G
    Am J Med Genet; 1994 Aug; 52(2):207-13. PubMed ID: 7802010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidermoid carcinoma of the lung in identical twins].
    Orbuch SJ; Perazzo DL; Porta J; Garrido C
    Medicina (B Aires); 1983; 43(1):16-20. PubMed ID: 6877086
    [No Abstract]   [Full Text] [Related]  

  • 24. HPV genotyping and HLA II analysis in a pedigree study of pediatric RRP: preliminary results.
    Comar M; Fabris A; Vatta S; Pelos G; Zocconi E; Campello C
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1935-9. PubMed ID: 16920199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mutations in NPHP4 in a consanguineous family with histological findings of focal segmental glomerulosclerosis.
    Mistry K; Ireland JH; Ng RC; Henderson JM; Pollak MR
    Am J Kidney Dis; 2007 Nov; 50(5):855-64. PubMed ID: 17954299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A deletion distinct from the classical homologous recombination of juvenile nephronophthisis type 1 (NPH1) allows exact molecular definition of deletion breakpoints.
    Otto E; Betz R; Rensing C; Schätzle S; Kuntzen T; Vetsi T; Imm A; Hildebrandt F
    Hum Mutat; 2000 Sep; 16(3):211-23. PubMed ID: 10980528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular analysis of crossing-over in the CMH in two Tunisian families with aplastic bone marrow].
    Lahiani NM; Kamoun A; Bellaaj H; Elloumi M; Souissi T; Makni H
    Pathol Biol (Paris); 2009 Jul; 57(5):383-7. PubMed ID: 18178036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Human histocompatibility HLA system. Considerations in the light of current concepts. VIII. Polymorphism of HLA-related MIC system].
    Kedzierska A; Turowski G
    Przegl Lek; 2001; 58(12):1076-8. PubMed ID: 12041026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic kidney disease, chromophobe renal cell carcinoma and TCF2 (HNF1 beta) mutations.
    Lebrun G; Vasiliu V; Bellanné-Chantelot C; Bensman A; Ulinski T; Chrétien Y; Grünfeld JP
    Nat Clin Pract Nephrol; 2005 Dec; 1(2):115-9. PubMed ID: 16932376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA genotyping in type-I autoimmune hepatitis in Western India.
    Amarapurkar DN; Patel ND; Amarapurkar AD; Kankonkar SR
    J Assoc Physicians India; 2003 Oct; 51():967-9. PubMed ID: 14719586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HLA and diseases].
    Décary F
    Union Med Can; 1981 Apr; 110(4):325-8. PubMed ID: 7245427
    [No Abstract]   [Full Text] [Related]  

  • 32. [The HLA system and nevobasaliomatosis (Gorlin-Goltz syndrome)].
    Linss G; Schielinsky C; Schmidt G
    Dermatol Monatsschr; 1981 Jun; 167(6):377-9. PubMed ID: 7274501
    [No Abstract]   [Full Text] [Related]  

  • 33. Theoretical aspects of HLA disease associations.
    Thomson G
    Prog Clin Biol Res; 1982; 103 Pt B():77-88. PubMed ID: 7163249
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recombination within the human leucocyte antigen].
    Luo Y; Sun YY; Xi YZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):427-30. PubMed ID: 16086283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA and infectious diseases.
    van Eden W; de Vries RR; van Rood JJ
    Prog Clin Biol Res; 1982; 103 Pt B():37-54. PubMed ID: 7163232
    [No Abstract]   [Full Text] [Related]  

  • 36. [HLA and association with illness].
    Wegener S
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):213-9. PubMed ID: 7919911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA genotyping is useful in the evaluation of the risk for coeliac disease in the 1st-degree relatives of patients with coeliac disease.
    Karinen H; Kärkkäinen P; Pihlajamäki J; Janatuinen E; Heikkinen M; Julkunen R; Kosma VM; Naukkarinen A; Laakso M
    Scand J Gastroenterol; 2006 Nov; 41(11):1299-304. PubMed ID: 17060123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HLA haplotypes in young myocardial infarct patients (a family study)].
    Kuz'mina AA; Latfullin IA
    Ter Arkh; 1998; 70(8):33-7. PubMed ID: 9770741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency in Spanish population of familial complement factor 2 type I deficits and associated HLA haplotypes.
    Antolín SC; Del Rey Cerros MJ; Sierra EM; Miñarro DO; Clemente J; Martínez LA; Peña PV; Panete MJ; Pérez PM; Paz-Artal E
    Hum Immunol; 2005 Oct; 66(10):1093-8. PubMed ID: 16386652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AGFAP method: applicability under different ascertainment schemes and a parental contributions test.
    Thomson G
    Genet Epidemiol; 1993; 10(5):289-310. PubMed ID: 8224808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.